Warning letterPosted May 26, 2026
FDA warning letter to Best Buy Bones, Inc.
CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food for Animals (PCAF)/Adulterated
FDA posted a warning letter to Best Buy Bones, Inc. on May 26, 2026; the letter is dated April 30, 2026. Subject: CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food for Animals (PCAF)/Adulterated. Issuing office: Office of Surveillance and Compliance.
On the record
- Company
- Best Buy Bones, Inc.
- Subject
- CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food for Animals (PCAF)/Adulterated
- Issuing office
- Office of Surveillance and Compliance
- Letter dated
- 2026-04-30
- Posted by FDA
- 2026-05-26
- Source
- FDA warning letters ↗
CFR cited
The record cites 9 sections of 21 CFR Parts 225 and 507.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Best Buy Bones, Inc
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Best Buy Bones, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.